BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9658367)

  • 1. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
    Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
    J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
    Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
    Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
    Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
    Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
    Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
    Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
    Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
    J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients.
    Okuda M; Hino K; Korenaga M; Yamaguchi Y; Katoh Y; Mukaide M; Kaneda Y; Minaminozono T; Okita K
    J Clin Gastroenterol; 2000 Jun; 30(4):425-8. PubMed ID: 10875473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis G: viroprevalence and seroconversion in a high-risk group of children.
    Hardikar W; Moaven LD; Bowden DS; Locarnini SA; Smith AL
    J Viral Hepat; 1999 Jul; 6(4):337-41. PubMed ID: 10607249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
    Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
    J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history.
    Mauser-Bunschoten EP; Damen M; Zaaijer HL; Sjerps M; Roosendaal G; Lelie PN; Cuypers HT; van den Berg HM
    Blood; 1998 Sep; 92(6):2164-8. PubMed ID: 9731076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences.
    Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Kashiwagi S
    Dig Dis Sci; 2000 Jan; 45(1):188-95. PubMed ID: 10695634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of hepatitis G virus RNA and antibodies to HGV envelope protein (anti-E2) in patients with liver injury in Japan].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 1999 Jun; 57(6):1274-8. PubMed ID: 10390982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females.
    Cheng PN; Chang TT; Yang MH; Hu SC; Young KC; Wu HL; Jen CM; Ko AW; Lu SC
    Liver; 2000 Jun; 20(3):222-7. PubMed ID: 10902972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GB virus C/hepatitis G virus infection in hemodialysis patients: determination of seroprevalence by a four-antigen recombinant immunoblot assay.
    Schröter M; Feucht HH; Schäfer P; Zöllner B; Laufs R
    J Med Virol; 1999 Mar; 57(3):230-4. PubMed ID: 10022792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B.
    Fattovich G; Ribero ML; Favarato S; Azzario F; Donato F; Giustina G; Fasola M; Pantalena M; Portera G; Tagger A
    Liver; 1998 Oct; 18(5):360-5. PubMed ID: 9831366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.